FDA Investigator Juanj N Wu

Juanj N Wu has conducted inspections on 54 sites in 5 countries as of 20 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
54
Last Inspection Date:
20 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100001150
Countries of Inspections:
Switzerland, France, United States of America, Germany, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Juanj N Wu:
Aaron J Poloni, Alexandria L Capuano, Allen F Hall, Althea A Williams, Amy M Cramer, Anderson, Angela Shepas, Benjamin W Anderson, Bichsa T Tran, Bruce R Burrell, Bryan A Galvez, Carla J Lundi, Catherine J Laufmann, Cathleen A Carr Sharpe, Christine I Shaw, Clint R Van Blaricom, Cynthia L Gorveatt, Daniel J Lahar, David G Whitman, David J Gasparovich, Dejon N Harris, Dirk L Lincoln, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Dr. Zhihao Qiu (Peter), PhD, Durell L Giles, Dustin P Tran, Elizabeth A Dakan, Elizabeth C Ajuzie, Eric W Anderson, Finn A Slizza, Gene D Arcy, Geoffrey M Leist, Greg K Keshishyan, Hanna L Potter, Iris C Macinnes, James A Lane, James R Fleckenstein, James R Montero, Janet Pulver, Javonica F Penn, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Jenny L Chisem, Jenny L Mccardell, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Gonzalez, Juanita Banuelos, Julian C Hanson, Kari M Johansen, Karl D Hezel, Katherine E Jacobitz, Kelvin Cheung, Kevin N Tran, Kwong P Lee, Leonard H Lavi, Leya A Grosch, Linda Galindo, Lisa A Bowden, Mark C Saale, Mark E Moen, Marlo Ianm Alintanahin, Mary R Hole, Matthew D Schnittker, Melanie W Pishnery, Minh D Phan, Natalie J Ayoub, Natalie J Reese, Ngoc B Kelsch, Paul F Rader, Rachelle M Deskins, Rebecca L Stephany, Richard K Vogel, Roberta K Smith, Sara M Onyango, Sara M Richardson, Sarah A Hassas, Scott K Zika, Seema S Singh, Selene T Torres, Shaquenta Y Perkins, Sharon I Gundersen, Sonya L Karsik, RAC, Stanley B Eugene, BS, BME, Stephen R Souza, Steven E Porter, Jr, Stuart W Russell, Sumit Sen, Sunny R Muir, Terri E Gibson, Thao T Kwan, Theresa Kirkham (NMI), Thomas C Mclean, CFS, Timothy C Grome, Trudy R Papson, Vashti E Bocker, Vicky L Cruz, Virgilio F Pacio, CSO, Walden H Lee, Wr Bowman, Yvette E Guillermo

Juanj N Wu's Documents

Publish Date Document Type Title
April, 2022 FDA 483 Excellus Holdings LLC - Form 483, 2022-04-23
June, 2021 FDA 483 Small Beginnings, Inc. - Form 483, 2021-06-23
October, 2022 EIR DIZZYDOCTOR SYSTEMS LLC - EIR, 2022-10-14
January, 2019 EIR Alere San Diego, Inc. - EIR, 2019-01-31
December, 2018 FDA 483 Med-Tech Resource LLC - Form 483, 2018-12-11
April, 2022 FDA 483 SoCal Healthy Hideway - Form 483, 2022-04-29
October, 2022 FDA 483 Response DIZZYDOCTOR SYSTEMS LLC - Form 483R, 2022-10-26
December, 2023 FDA 483 Gecko Labs, LLC - Form 483, 2023-12-14
April, 2019 FDA 483 Emerge Diagnostics Inc. - Form 483, 2019-04-26
August, 2019 FDA 483 CLARIFY MEDICAL INC - Form 483, 2019-08-19
October, 2021 FDA 483 Syntron Bioresearch Inc - Form 483, 2021-10-14
January, 2019 FDA 483 Alere San Diego, Inc. - Form 483, 2019-01-11
January, 2020 FDA 483 Optical Connection LLC - Form 483, 2020-01-16
August, 2023 FDA 483 True Function Laboratory, Inc. - Form 483, 2023-08-10
February, 2019 FDA 483 Lusys Laboratories, Inc. - Form 483, 2019-02-07
April, 2023 FDA 483 Epitope Diagnostics, Inc. - Form 483, 2023-04-28
March, 2022 FDA 483 Chemtron Biotech, Inc - Form 483, 2022-03-18
June, 2023 FDA 483 Dr. Joel Kaplan Inc. - Form 483, 2023-06-30
November, 2019 EIR Spectrum Assembly Inc - EIR, 2019-12-23
May, 2024 FDA 483 PATHWAY MEDTECH, LLC - Form 483, 2024-05-22
December, 2021 FDA 483 Sacks Holdings, Inc. - Form 483, 2021-12-10
March, 2023 FDA 483 Tandem Diabetes Care, Inc. - Form 483, 2023-03-23
February, 2023 FDA 483 Bien-Air Surgery SA - Form 483, 2023-02-16
August, 2021 FDA 483 Trinity Orthopedics, LLC - Form 483, 2021-08-27
June, 2024 FDA 483 Caris Life Sciences, Inc - Form 483, 2024-06-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more